Related references
Note: Only part of the references are listed.Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as Microbicides
Philippe Selhorst et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques
Jessica Kenney et al.
PLOS ONE (2011)
Abundant Expression of HIV Target Cells and C-Type Lectin Receptors in the Foreskin Tissue of Young Kenyan Men
Taha Hirbod et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The Role of Antibodies in HIV Vaccines
John R. Mascola et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use
Jan Balzarini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Identification of a Dendrimeric Heparan Sulfate-Binding Peptide That Inhibits Infectivity of Genital Types of Human Papillomaviruses
Manuela Donalisio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Evaluation of Viability, Integrity, and Inflammation in Genital Epithelia upon Exposure to Pharmaceutical Excipients and Candidate Microbicides
Youssef Gali et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope
Bart Hoorelbeke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate
Anna Luganini et al.
ANTIVIRAL RESEARCH (2010)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009)
Marie-Pierre de Bethune
ANTIVIRAL RESEARCH (2010)
Evaluation of antiretrovirals in animal models of HIV infection
Koen K. A. Van Rompay
ANTIVIRAL RESEARCH (2010)
The antiviral protein cyanovirin-N: the current state of its production and applications
Sheng Xiong et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2010)
Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-Importance of slow dissociation and relaxation rates for antiviral efficacy
Malin Elinder et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor
Laura De Luca et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom (R) formulations in Cameroonian women
Francois-Xavier Mbopi-Keou et al.
CONTRACEPTION (2010)
Results of a safety and feasibility study of the diaphragm used with ACIDFORM Gel or K-Y® Jelly
Claire E. von Mollendorf et al.
CONTRACEPTION (2010)
The risk of HIV drug resistance following implementation of pre-exposure prophylaxis
David A. M. C. van de Vijver et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir
Todd J. Johnson et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1
Willie W. L. Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile
Dana Huskens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Historical Perspective on HIV-Exposed Seronegative Individuals: Has Nature Done the Experiment for Us?
Gene Shearer et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Determinants of Protection among HIV-Exposed Seronegative Persons: An Overview
Michael M. Lederman et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Infection of Macaques after Vaginal Exposure to Cell-Associated Simian Immunodeficiency Virus
Bettina Salle et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Protection of Rhesus Macaques from Vaginal Infection by Vaginally Delivered Maraviroc, an Inhibitor of HIV-1 Entry via the CCR5 Co-Receptor
Ronald S. Veazey et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Viologen Dendrimers as Antiviral Agents: The Effect of Charge Number and Distance
Simona Asaftei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity
Youssef Gali et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users
Katharine J. Bar et al.
JOURNAL OF VIROLOGY (2010)
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial
Sheena McCormack et al.
LANCET (2010)
Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates
Y. Ganor et al.
MUCOSAL IMMUNOLOGY (2010)
Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin's role in HIV transmission
K. M. Fahrbach et al.
MUCOSAL IMMUNOLOGY (2010)
Targeting early infection to prevent HIV-1 mucosal transmission
Ashley T. Haase
NATURE (2010)
Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication
Frauke Christ et al.
NATURE CHEMICAL BIOLOGY (2010)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction
Andreas Hinz et al.
PLOS ONE (2010)
Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing
Will Fischer et al.
PLOS ONE (2010)
Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity
David Tyssen et al.
PLOS ONE (2010)
Oral Pre-Exposure Prophylaxis by Anti-Retrovirals Raltegravir and Maraviroc Protects against HIV-1 Vaginal Transmission in a Humanized Mouse Model
C. Preston Neff et al.
PLOS ONE (2010)
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
Katie J. Doores et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI
Kyeong-Ae Kim et al.
RETROVIROLOGY (2010)
Anti-retroviral activity of TRIM5 alpha
Emi E. Nakayama et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin
Kabamba B. Alexandre et al.
VIROLOGY (2010)
Sexual risk behaviour for transmission of HIV in men who have sex with men: recent findings and potential interventions
Lisa M. McDaid et al.
CURRENT OPINION IN HIV AND AIDS (2010)
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men
Hui Li et al.
PLOS PATHOGENS (2010)
HIV-1 infection of human penile explant tissue and protection by candidate microbicides
Lucia Fischetti et al.
AIDS (2009)
Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women
Annalene A. Nel et al.
AIDS (2009)
Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring
J. Romano et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
P. Fletcher et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of Treatment of Asymptomatic Bacterial Vaginosis on HIV-1 Shedding in the Genital Tract among Women on Antiretroviral Therapy: A Pilot Study
Carla Moreira et al.
CLINICAL INFECTIOUS DISEASES (2009)
A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom® formulations in women from Cameroon
Francois-Xavier Mbopi-Keou et al.
CONTRACEPTION (2009)
Safety and Pharmacokinetics of Dapivirine Delivery From Matrix and Reservoir Intravaginal Rings to HIV-Negative Women
Annalene Nel et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells
Ana Ceballos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1
Brandon F. Keele et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
Jesus F. Salazar-Gonzalez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models
Viviana Buffa et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe
Jurgen Vercauteren et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
HIV Type 1 Infection in Women: Increased Transcription of HIV Type 1 in Ectocervical Tissue Explants
Susana N. Asin et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Topically Applied Recombinant Chemokine Analogues Fully Protect Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge
Ronald S. Veazey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission
Manish Sagar et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus
Samuel K. Lai et al.
JOURNAL OF VIROLOGY (2009)
Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants
M. -R. Abrahams et al.
JOURNAL OF VIROLOGY (2009)
Glycerol monolaurate prevents mucosal SIV transmission
Qingsheng Li et al.
NATURE (2009)
A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy
Federica Crostarosa et al.
PLOS ONE (2009)
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
Haruo Tanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
Barry R. O'Keefe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
HIV-1 transmission and early evolution: whole genome analysis
J. T. Herbeck et al.
RETROVIROLOGY (2009)
Elucidating the elite: mechanisms of control in HIV-1 infection
Karen A. O'Connell et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1
Richard E. Haaland et al.
PLOS PATHOGENS (2009)
New insights on interactions between HIV-1 and HSV-2
Sinéad Delany-Moretlwe et al.
Current Infectious Disease Reports (2009)
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies
Julius Atashili et al.
AIDS (2008)
Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection
Katty Terrazas-Aranda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course
Nicole Prada et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
No increase in cervicovaginal proinflammatory cytokines after carraguard use in aplacebo-controlled randomized clinical trial
Liesbeth J. M. Bollen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Chemokine Analogues Show Suitable Stability for Development as Microbicides
Fabrice Cerini et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Six-Day Randomized Safety Trial of Intravaginal Lime Juice
Christine K. Mauck et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides
Yven Van Herrewege et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
HIV-1 variation before seroconversion in men who have sex with men: Analysis of acute/early HIV infection in the multicenter AIDS cohort study
Geoffrey S. Gottlieb et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120
Anna Forsman et al.
JOURNAL OF VIROLOGY (2008)
Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice
Lorena Garaicoechea et al.
JOURNAL OF VIROLOGY (2008)
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing
Jesus F. Salazar-Gonzalez et al.
JOURNAL OF VIROLOGY (2008)
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis
Kimberly A. Powers et al.
LANCET INFECTIOUS DISEASES (2008)
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission
Lut Van Damme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria
Paul J. Feldblum et al.
PLOS ONE (2008)
Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa
Laith J. Abu-Raddad et al.
PLOS ONE (2008)
Topical Oestrogen Keratinises The Human Foreskin and May Help Prevent HIV Infection
Andrew J. Pask et al.
PLOS ONE (2008)
Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in Nigeria
Vera Halpern et al.
PLOS ONE (2008)
Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide
Hubert Gaertner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection
Brandon F. Keele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prevalence of HIV and other sexually transmissible infections in relation to lemon or lime juice douching among female sex workers in Jos, Nigeria
Godwin Imade et al.
SEXUAL HEALTH (2008)
Vaginal microbicide and diaphragm use for sexually transmitted infection prevention: A randomized acceptability and feasibility study among high-risk women in Madagascar
Frieda M. Behets et al.
SEXUALLY TRANSMITTED DISEASES (2008)
Viral characteristics of transmitted HIV
Cynthia A. Derdeyn et al.
CURRENT OPINION IN HIV AND AIDS (2008)
Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel
Martin Cranage et al.
PLOS MEDICINE (2008)
Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice
Paul W. Denton et al.
PLOS MEDICINE (2008)
Carraguard vaginal gel safety in HIV-Positive women and men in South Africa
Janneke H. H. M. van de Wiigert et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Semen-derived amyloid fibrils drastically enhance HIV infection
Jan Muench et al.
CELL (2007)
Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY Jelly used with a diaphragm
D'Nyce L. Williams et al.
SEXUALLY TRANSMITTED DISEASES (2007)
Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN
Juan Sabatte et al.
JOURNAL OF VIROLOGY (2007)
Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses
Ping Chen et al.
JOURNAL OF VIROLOGY (2007)
Lime juice as a candidate microbicide? An open-label safety trial of 10% and 20% lime juice used vaginally
Anke Hemmerling et al.
JOURNAL OF WOMENS HEALTH (2007)
Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide
P. Emau et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2007)
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial
Nancy S. Padian et al.
LANCET (2007)
A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides
Yven Van Herrewege et al.
ANTIVIRAL RESEARCH (2007)
Exploiting the defensive sugars of HIV-1 for drug and vaccine design
Christopher N. Scanlan et al.
NATURE (2007)
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Rob C. Roovers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial
Robert C. Bailey et al.
LANCET (2007)
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
Ronald H. Gray et al.
LANCET (2007)
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Tongqing Zhou et al.
NATURE (2007)
Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to neutralization during clade C infection
Rong Rong et al.
JOURNAL OF VIROLOGY (2007)
Circumcision and HIV transmission
Thomas C. Quinn
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers
Vicky A. Jespers et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1
Florian Hladik et al.
IMMUNITY (2007)
Carrageenan/MIV-150 (PC-815), a combination microbicide
Jose A. Fernandez-Romero et al.
SEXUALLY TRANSMITTED DISEASES (2007)
Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14
Janice J. Liu et al.
CELLULAR MICROBIOLOGY (2007)
Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea
Neha Pant et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Safety and acceptability of the candidate microbicide Carraguard in Thai women: Findings from a phase II clinical trial
Peter H. Kilmarx et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Young age is a risk factor for HIV among female sex workers - An experience from India
Kamalesh Sarkar et al.
JOURNAL OF INFECTION (2006)
Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity
Manish Sagar et al.
JOURNAL OF VIROLOGY (2006)
ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: Optimal candidate for microbicide combinations
Ana C. G. Tuyama et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study
Jill L. Schwartz et al.
CONTRACEPTION (2006)
Potential HIV-1 target cells in the human penis
Scott G. McCoombe et al.
AIDS (2006)
Potent anti-HIV activity of scytovirin domain 1 peptide
Changyun Xiong et al.
PEPTIDES (2006)
Formatted anti-tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
Ken Coppieters et al.
ARTHRITIS AND RHEUMATISM (2006)
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women
WM El-Sadr et al.
AIDS (2006)
Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
Toya Nath Baral et al.
NATURE MEDICINE (2006)
Cellulose acetate 1,2-benzenedicarboxylate inhibits infection by cell-free and cell-associated primary HIV-1 isolates
Hong Lu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Microbicides and other topical strategies to prevent vaginal transmission of HIV
MM Lederman et al.
NATURE REVIEWS IMMUNOLOGY (2006)
In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1
MM Hossain et al.
JOURNAL OF VIROLOGY (2006)
Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product
E Amaral et al.
CONTRACEPTION (2006)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
E De Genst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Documenting intermenstrual bleeding in a vaginal microbicide study: Case reports and lessons learned
S Joshi et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections
BA Donoval et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
EE Freeman et al.
AIDS (2006)
Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody
P Verheesen et al.
HUMAN MOLECULAR GENETICS (2006)
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: A double-blind placebo-controlled trial
MJ Keller et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission
Richard A. Cone et al.
BMC INFECTIOUS DISEASES (2006)
Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Jorge Martinez et al.
ANTIVIRAL RESEARCH (2006)
Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel
IM Malonza et al.
AIDS (2005)
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion
RS Veazey et al.
NATURE (2005)
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings
RK Malcolm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial
B Auvert et al.
PLOS MEDICINE (2005)
Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus
T Boadi et al.
AIDS (2005)
Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques
M Ratterree et al.
AIDS (2005)
Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model
SS Olmsted et al.
BMC INFECTIOUS DISEASES (2005)
The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells
P Fletcher et al.
JOURNAL OF VIROLOGY (2005)
Candidate sulfonated and sulfated topical microbicides: Comparison of anti-human immunodeficiency virus activities and mechanisms of action
IA Scordi-Bello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Toward a live microbial microbicide for HIV: Commensal bacteria secreting an HIV fusion inhibitor peptide
S Rao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus
CJ Miller et al.
JOURNAL OF VIROLOGY (2005)
Male tolerance of ACIDFORM gel
JL Schwartz et al.
CONTRACEPTION (2005)
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda
MJ Wawer et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection
SW Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Selection for human immunodeficiency virus type I envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels
B Chohan et al.
JOURNAL OF VIROLOGY (2005)
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
JJ Mattapallil et al.
NATURE (2005)
Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.
T Mori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: Strategy to study HIV preclinical interventions in nonhuman primates
RA Otten et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo
E Dolk et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Efficient cancer therapy with a nanobody-based conjugate
V Cortez-Retamozo et al.
CANCER RESEARCH (2004)
Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120
H Chiba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission
CA Derdeyn et al.
SCIENCE (2004)
Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers
J Grobler et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody
MY Zhang et al.
JOURNAL OF VIROLOGY (2004)
Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes
M Sagar et al.
JOURNAL OF VIROLOGY (2004)
The role of sexually transmitted diseases in HIV transmission
SR Galvin et al.
NATURE REVIEWS MICROBIOLOGY (2004)
PSC-RANTES blocks R5 human immunodeficiency virus infection of langerhans cells isolated from individuals with a variety of CCR5 diplotypes
T Kawamura et al.
JOURNAL OF VIROLOGY (2004)
Expression of DC-SIGN in human foreskin may facilitate sexual transmission of HIV
EJ Soilleux et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides
Y Van Herrewege et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5
MM Lederman et al.
SCIENCE (2004)
Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type
K Ritola et al.
JOURNAL OF VIROLOGY (2004)
Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models
CC Tsai et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Inhibiting sexual transmission of HIV-1 infection
RJ Shattock et al.
NATURE REVIEWS MICROBIOLOGY (2003)
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4
TLY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Carrageenan formulation prevents macrophage trafficking from vagina: Implications for microbicide development
ME Perotti et al.
BIOLOGY OF REPRODUCTION (2003)
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme
M Dumoulin et al.
NATURE (2003)
Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel - 3 randomized trials in healthy low-risk men and HIV-positive men
SR Tabet et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
Thermoreversible gel formulation containing sodium lauryl sulfate as a potential contraceptive device
C Haineault et al.
BIOLOGY OF REPRODUCTION (2003)
Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation
S Di Fabio et al.
AIDS (2003)
R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms
T Kawamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques
CC Tsai et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Lactobacillus crispatus capsules:: Single-use safety study in the Macaca nemestrina model
DL Patton et al.
SEXUALLY TRANSMITTED DISEASES (2003)
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
DA Calarese et al.
SCIENCE (2003)
DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization
MAD Antonio et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781
A Zussman et al.
AIDS (2003)
Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120
RS Veazey et al.
NATURE MEDICINE (2003)
Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women
KH Mayer et al.
AIDS (2003)
Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes
L Martin et al.
NATURE BIOTECHNOLOGY (2003)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
Virus population homogenization following acute human immunodeficiency virus type 1 infection
GH Learn et al.
JOURNAL OF VIROLOGY (2002)
Microbicides - evaluating multiple formulations of C31G
R Bax et al.
CONTRACEPTION (2002)
Safety of single daily use for one week of C31G HEC gel in women
SA Ballagh et al.
CONTRACEPTION (2002)
Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis
SL Achilles et al.
SEXUALLY TRANSMITTED DISEASES (2002)
The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells
AJ Quayle
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2002)
Memory CD4+ T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system
P Gupta et al.
JOURNAL OF VIROLOGY (2002)
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers:: a randomised controlled trial
L Van Damme et al.
LANCET (2002)
Two novel vaginal microbicides (polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis
JA Simoes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus
EM Long et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2002)
Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of dead-end gp41 six-helix bundles
AR Neurath et al.
BMC INFECTIOUS DISEASES (2002)
Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses
J Piret et al.
CURRENT DRUG TARGETS (2002)
Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells
G Meng et al.
NATURE MEDICINE (2002)
Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques
B Jameson et al.
JOURNAL OF VIROLOGY (2002)
Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis
A Wald et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Cellulose sulfate: tolerance and acceptability of penile application
C Mauck et al.
CONTRACEPTION (2001)
Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study
C Mauck et al.
CONTRACEPTION (2001)
Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate
ND Christensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults
P Barditch-Crovo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120
AR Neurath et al.
BMC INFECTIOUS DISEASES (2001)
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa
OS Fideli et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Thermoreversible gel formulations containing sodium lauryl sulfate or n-lauroylsarcosine as potential topical microbicides against sexually transmitted diseases
S Roy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda
RH Gray et al.
LANCET (2001)
Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection
AB Moscicki et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States
KH Mayer et al.
CLINICAL INFECTIOUS DISEASES (2001)
Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide
C Coggins et al.
SEXUALLY TRANSMITTED INFECTIONS (2000)
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs
VS Torre et al.
JOURNAL OF VIROLOGY (2000)
A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women
L Van Damme et al.
SEXUALLY TRANSMITTED INFECTIONS (2000)
The rate at which human sperm are immobilized and killed by mild acidity
SS Olmsted et al.
FERTILITY AND STERILITY (2000)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
TBH Geijtenbeek et al.
CELL (2000)
Isolation of antigen specific Llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae
LGJ Frenken et al.
JOURNAL OF BIOTECHNOLOGY (2000)
Viral load and heterosexual transmission of human immunodeficiency virus type 1
TC Quinn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
M Moulard et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
